Roku is an entertainment business based in the US. Roku stocks (ROKU.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $327.12 – a decrease of 5.65% over the previous week. Roku employs 1,925 staff and has a trailing 12-month revenue of around $2 billion.
Since the stock market crash in March caused by coronavirus, Roku's stock price has had significant positive movement.
Its last market close was $327.12, which is 63.51% up on its pre-crash value of $119.38 and 461.87% up on the lowest point reached during the March crash when the stocks fell as low as $58.22.
If you had bought $1,000 worth of Roku stocks at the start of February 2020, those stocks would have been worth $701.37 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,564.62.
|Latest market close||$327.12|
|52-week range||$143.21 - $486.72|
|50-day moving average||$394.9944|
|200-day moving average||$377.4777|
|Wall St. target price||$450.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.871|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 month (2021-06-23)||-22.43%|
Valuing Roku stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Roku's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Roku's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 483x. In other words, Roku stocks trade at around 483x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.
Roku's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$173.7 million.
The EBITDA is a measure of a Roku's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$2 billion|
|Operating margin TTM||5.45%|
|Gross profit TTM||USD$808.2 million|
|Return on assets TTM||2.75%|
|Return on equity TTM||7.28%|
|Market capitalisation||USD$55.7 billion|
TTM: trailing 12 months
There are currently 3.8 million Roku stocks held short by investors – that's known as Roku's "short interest". This figure is 1.2% up from 3.7 million last month.
There are a few different ways that this level of interest in shorting Roku stocks can be evaluated.
Roku's "short interest ratio" (SIR) is the quantity of Roku stocks currently shorted divided by the average quantity of Roku stocks traded daily (recently around 4.2 million). Roku's SIR currently stands at 0.9. In other words for every 100,000 Roku stocks traded daily on the market, roughly 900 stocks are currently held short.
However Roku's short interest can also be evaluated against the total number of Roku stocks, or, against the total number of tradable Roku stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Roku's short interest could be expressed as 0.03% of the outstanding stocks (for every 100,000 Roku stocks in existence, roughly 30 stocks are currently held short) or 0.033% of the tradable stocks (for every 100,000 tradable Roku stocks, roughly 33 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Roku.
Find out more about how you can short Roku stock.
We're not expecting Roku to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Over the last 12 months, Roku's stocks have ranged in value from as little as $143.21 up to $486.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Roku's is 1.7787. This would suggest that Roku's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Player. Its platform allows users to discover and access various movies and TV episodes, as well as live sports, music, news, and others. As of December 31, 2020, the company had 51.2 million active accounts. It also provides digital and video advertising, content distribution, subscription, and billing services, as well as other commerce transactions, brand sponsorship and promotions, and audience development campaigns; and manufactures, sells, and licenses smart TVs under the Roku TV name. In addition, the company offers streaming players, and audio products and accessories under the Roku brand name; and sells branded channel buttons on remote controls. It provides its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Canada, the United Kingdom, France, the Republic of Ireland, Mexico, Brazil, and other Latin American countries. Roku, Inc. was founded in 2002 and is headquartered in San Jose, California.
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
Everything we know about the Core & Main IPO, plus information on how to buy in.
Everything we know about the Caribou Bioscience IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.